MEDtalk: Can you describe what characterizes the group of patients with non-metastatic castration-resistant prostate cancer?

Best Practice Nordic | Jun 2020 | ASCO20 Virtual |

In this MEDtalk Eric J. Small, MD and principal investigator of the SPARTAN study describe what characterizes the group of patients with nonmetastatic castration-resistant prostate cancer?